Kidney function and bone mineral density in chronic kidney disease patients.

Clin Kidney J

Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Republic of Korea.

Published: September 2024

Background: Bone mineral density (BMD) predicts fracture risk in patients with chronic kidney disease (CKD) and in the general population. However, few studies have investigated risk factors for bone loss in patients with CKD. The aim of this study was to investigate whether renal function is associated with the rate of BMD decline.

Methods: A prospective cohort study included 1006 patients with CKD stages 2-4 between 2011 and 2016. BMD was measured using dual-energy X-ray absorptiometry at baseline and 4 years. The eGFR was measured 2-6 times during the 4-year follow-up. We analyzed the decline in bone mineral density according to CKD stage and further compared the rate of BMD decline according to eGFR trajectories at each stage.

Results: Advanced CKD stage was associated with a faster rate of decline in total hip BMD [stage 2 -0.23, stage 3A -0.39, stage 3B -0.80, stage 4 -1.23% change/year in men (< .001); stage 2 -0.86, stage 3A -1.19, stage 3B -1.20, stage 4 -1.58% change/year in women ( < .03)]. Two distinct eGFR trajectories (Class 1 stable group; Class 2 rapid decline group) were observed. The rapid decline group showed a trend toward an increased rate of decline in total hip BMD. Subgroup analysis according to eGFR trajectories revealed a significant difference in BMD decline rate between stable and rapid decline groups.

Conclusions: Advanced CKD stage and accelerated decline in renal function were associated with rapid BMD decline in non-dialysis patients with CKD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11873793PMC
http://dx.doi.org/10.1093/ckj/sfae248DOI Listing

Publication Analysis

Top Keywords

bone mineral
12
mineral density
12
chronic kidney
8
kidney disease
8
patients ckd
8
rate bmd
8
ckd stage
8
bmd
5
ckd
5
stage
5

Similar Publications

Cystatin C is associated with osteoporosis and fractures: An observational study based on Mendelian randomization analysis.

Zhong Nan Da Xue Xue Bao Yi Xue Ban

October 2024

Research for Genetic Epidemiology and Genomics, School of Public Health, Suzhou Medical College of Soochow University, Suzhou Jiangsu 215123, China.

Objectives: Osteoporosis is characterized by decreased bone mass and damaged bone microstructure, often leading to fragility fractures. Low bone mineral density is a key risk factor for fractures. Serum cystatin C (CysC), an endogenous marker of glomerular filtration rate, is negatively correlated with bone mineral density and may be a potential risk factor for osteoporosis.

View Article and Find Full Text PDF

Background: Many prognostic factors associated with healing after arthroscopic rotator cuff repair have been evaluated. It has been shown from previous literature that osteoporosis is an independent risk factor for poor healing and increased need for revision surgery. To our knowledge, there has not been a study reporting patient reported outcomes (PROs) for arthroscopic rotator cuff repair in patients with osteoporosis.

View Article and Find Full Text PDF

Bone undergoes life-long remodelling, in which disorders of bone remodelling could occur in many pathological conditions including osteoporosis. Understanding the cellular metabolism of osteoclasts is key to developing new treatments for osteoporosis, a disease that affects over 200 million women worldwide per annum. We found that human osteoclast differentiation from peripheral blood mononuclear cells (PBMCs) derived from 8 female patients is featured with a distinct gene expression profile of mitochondrial biogenesis.

View Article and Find Full Text PDF

Obesity is a global health challenge associated with significant metabolic and cardiovascular risks. Bariatric surgery and GLP-1 receptor agonists (GLP-1RAs) are effective interventions for weight loss and metabolic improvement, yet their comparative effects on systemic metabolism-particularly energy metabolism, bone health, and heart function-remain unclear. In this study, obese male mice underwent vertical sleeve gastrectomy (VSG), 6 weeks of GLP-1RA (semaglutide) treatment, or sham procedure with saline injection as controls.

View Article and Find Full Text PDF

Introduction: The authors of the latest recommendations state that osteoporosis diagnosis should not rely solely on densitometric (DXA) criteria. Fracture risk assessment is crucial for determining diagnosis and intervention thresholds. Comprehensive assessment of fracture risk requires consideration of bone mineral density (BMD) results, use of risk calculators like Fracture Risk Assessment Tool (FRAXTM), and analysis of clinical and lifestyle factors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!